BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33548204)

  • 1. Hepatobiliary morbidities detected by ultrasonography in Opisthorchis viverrini-infected patients before and after praziquantel treatment: a five-year follow up study.
    Mairiang E; Laha T; Kaewkes S; Loukas A; Bethony J; Brindley PJ; Sripa B
    Acta Trop; 2021 May; 217():105853. PubMed ID: 33548204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand.
    Thinkhamrop K; Khuntikeo N; Sithithaworn P; Thinkhamrop W; Wangdi K; Kelly MJ; Suwannatrai AT; Gray DJ
    Infect Dis Poverty; 2019 Mar; 8(1):18. PubMed ID: 30890188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonography assessment of hepatobiliary abnormalities in 3359 subjects with Opisthorchis viverrini infection in endemic areas of Thailand.
    Mairiang E; Laha T; Bethony JM; Thinkhamrop B; Kaewkes S; Sithithaworn P; Tesana S; Loukas A; Brindley PJ; Sripa B
    Parasitol Int; 2012 Mar; 61(1):208-11. PubMed ID: 21771664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonographic features of hepatobiliary pathology in opisthorchiasis and opisthorchiasis-associated cholangiocarcinoma.
    Mairiang E
    Parasitol Int; 2017 Aug; 66(4):378-382. PubMed ID: 27956092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent advanced periductal fibrosis is associated with cagA-positive Helicobacter pylori infection in post-praziquantel treatment of opisthorchiasis.
    Phung HTT; Deenonpoe R; Suttiprapa S; Mairiang E; Edwards SW; Sripa B
    Helicobacter; 2022 Aug; 27(4):e12897. PubMed ID: 35527695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis.
    Wangboon C; Yongvanit P; Loilome W; Thanan R; Worasith C; Eamudomkarn C; Chamadol N; Mairiang E; Sithithaworn J; Saichua P; Sripa B; Khuntikeo N; Bethony JM; Sithithaworn P
    Am J Trop Med Hyg; 2018 Jun; 98(6):1763-1769. PubMed ID: 29637887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased risk of cholangiocarcinogenesis following repeated cycles of Opisthorchis viverrini infection-praziquantel treatment: Magnetic Resonance Imaging (MRI) and histopathological study in a hamster model.
    Hanpanich P; Laha T; Sripa B; Mairiang E; Sereerak P; Upontain S; Tangkawattana P; Brindley PJ; Tangkawattana S
    Parasitol Int; 2017 Aug; 66(4):464-470. PubMed ID: 27143606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound screening for Opisthorchis viverrini-associated cholangiocarcinomas: experience in an endemic area.
    Mairiang E; Chaiyakum J; Chamadol N; Laopaiboon V; Srinakarin J; Kunpitaya J; Sriamporn S; Suwanrungruang K; Vatanasapt V
    Asian Pac J Cancer Prev; 2006; 7(3):431-3. PubMed ID: 17059338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced neutrophil functions during Opisthorchis viverrini infections and correlation with advanced periductal fibrosis.
    Salao K; Spofford EM; Price C; Mairiang E; Suttiprapa S; Wright HL; Sripa B; Edwards SW
    Int J Parasitol; 2020 Feb; 50(2):145-152. PubMed ID: 32006550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reinfection by Opisthorchis Viverrini after Treatment with Praziquantel.
    Saengsawang P; Promthet S; Bradshaw P
    Asian Pac J Cancer Prev; 2016; 17(2):857-62. PubMed ID: 26925692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma.
    Sudsarn P; Boonmars T; Ruangjirachuporn W; Namwat N; Loilome W; Sriraj P; Aukkanimart R; Nadchanan W; Jiraporn S
    Pathol Oncol Res; 2016 Jan; 22(1):57-65. PubMed ID: 26277607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtle to severe hepatobiliary morbidity in Opisthorchis viverrini endemic settings in southern Laos.
    AyƩ Soukhathammavong P; Rajpho V; Phongluxa K; Vonghachack Y; Hattendorf J; Hongvanthong B; Rasaphon O; Sripa B; Akkhavong K; Hatz C; Odermatt P
    Acta Trop; 2015 Jan; 141(Pt B):303-9. PubMed ID: 25275346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for Opisthorchis viverrini Infection in Nong Khai Province, Thailand.
    Chudthaisong N; Promthet S; Bradshaw P
    Asian Pac J Cancer Prev; 2015; 16(11):4593-6. PubMed ID: 26107209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention].
    Buisson Y
    Bull Soc Pathol Exot; 2017 Feb; 110(1):61-67. PubMed ID: 28105582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection with Opisthorchis viverrini and use of praziquantel among a working-age population in northeast Thailand.
    Saengsawang P; Promthet S; Bradshaw P
    Asian Pac J Cancer Prev; 2013; 14(5):2963-6. PubMed ID: 23803062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke
    Surapaitoon A; Suttiprapa S; Mairiang E; Khuntikeo N; Pairojkul C; Bethony J; Brindley PJ; Sripa B
    Korean J Parasitol; 2017 Jun; 55(3):295-304. PubMed ID: 28719954
    [No Abstract]   [Full Text] [Related]  

  • 17. A combination of praziquantel and the traditional medicinal plant Thunbergia laurifolia on Opisthorchis viverrini infection and cholangiocarcinoma in a hamster model.
    Wonkchalee N; Boonmars T; Laummaunwai P; Aromdee C; Hahnvajanawong C; Wu Z; Sriraj P; Aukkanimart R; Chamgramol Y; Pairojkul C; Juasook A; Sudsarn P
    Parasitol Res; 2013 Dec; 112(12):4211-9. PubMed ID: 24057695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand.
    Haswell-Elkins MR; Mairiang E; Mairiang P; Chaiyakum J; Chamadol N; Loapaiboon V; Sithithaworn P; Elkins DB
    Int J Cancer; 1994 Nov; 59(4):505-9. PubMed ID: 7960220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos.
    Sripa B; Bethony JM; Sithithaworn P; Kaewkes S; Mairiang E; Loukas A; Mulvenna J; Laha T; Hotez PJ; Brindley PJ
    Acta Trop; 2011 Sep; 120 Suppl 1(Suppl 1):S158-68. PubMed ID: 20655862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-sectional patterns of hepatobiliary abnormalities and possible precursor conditions of cholangiocarcinoma associated with Opisthorchis viverrini infection in humans.
    Elkins DB; Mairiang E; Sithithaworn P; Mairiang P; Chaiyakum J; Chamadol N; Loapaiboon V; Haswell-Elkins MR
    Am J Trop Med Hyg; 1996 Sep; 55(3):295-301. PubMed ID: 8842118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.